Legislation: batch B — IL IN KS KY LA MA MD ME MI MN

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/md/2021/hb-643.md

@@ -0,0 +1,71 @@
+---
+type: "Bill"
+title: "Public Health - Cosmetic Products - Ingredient Prohibition"
+description: "Public Health - Cosmetic Products - Ingredient Prohibition"
+jurisdiction: "us/states/md"
+legislature: "Maryland General Assembly"
+session: "2021"
+identifier: "HB 643"
+citation: "Maryland HB 643 (2021)"
+classification: ["bill"]
+subjects: []
+status: "enacted"
+primary_sponsors: ["Palakovich Carr"]
+version_count: 3
+action_count: 14
+vote_count: 2
+first_action: "2021-01-22"
+last_action: "2021-05-30"
+source: "openstates"
+source_identifier: "ocd-bill/7a77344a-5267-461e-9ffa-d5c5a98150ab"
+source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0643?ys=2021RS&search=True"
+source_hash: "0e5889465d1f685f905f510dce9a89c7d68c2f537ab3f3b2ded98c40588f611a"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-md"]
+---
+
+# Maryland HB 643 (2021) — Public Health - Cosmetic Products - Ingredient Prohibition
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **Chapter - Public Health - Cosmetic Products - Ingredient Prohibition** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/Chapters_noln/CH_490_hb0643t.pdf)
+2. **First - Public Health - Cosmetic Products - Ingredient Prohibition** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/bills/hb/hb0643f.pdf)
+3. **Third - Public Health - Cosmetic Products - Ingredient Prohibition** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/bills/hb/hb0643t.pdf)
+
+## Votes
+
+- On Third Reading — **99–35** (pass) · lower
+- On Third Reading — **47–0** (pass) · upper
+
+## Sponsors
+
+- Palakovich Carr — primary (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2021-01-22** First Reading Health and Government Operations `referral-committee`
+- **2021-01-29** Hearing 2/16 at 1:30 p.m.
+- **2021-03-15** Favorable with Amendments Report by Health and Government Operations `committee-passage-favorable`
+- **2021-03-16** Favorable with Amendments { `committee-passage-favorable`
+- **2021-03-16** Second Reading Passed with Amendments
+- **2021-03-17** Third Reading Passed `passage`
+- **2021-03-18** Referred Finance `referral-committee`
+- **2021-03-19** Hearing 3/24 at 1:00 p.m.
+- **2021-04-05** Favorable Report by Finance `committee-passage-favorable`
+- **2021-04-05** Favorable Adopted `committee-passage-favorable`
+- **2021-04-05** Second Reading Passed
+- **2021-04-06** Third Reading Passed `passage`
+- **2021-04-06** Returned Passed
+- **2021-05-30** Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 490 `became-law`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/7a77344a-5267-461e-9ffa-d5c5a98150ab`. Confidence: reported (aggregated from official Maryland legislature records).
+